-transparent.png){kind=logo}
Two patients with acute nonlymphocytic leukemia (ANLL) developed peripheral motor and sensory neuropathies after consolidation chemotherapy with high-dose cytosine arabinoside (ara-C), daunorubicin, and asparaginase. Evidence for ara-C and daunorubicin-induced peripheral neuropathies is reported. Despite the frequent use of these agents, only two cases of peripheral neuropathy after systemic therapy have been previously described; neurotoxic effects may be potentiated and become clinically important when the three drugs are used in combination.
Related Publications
B L Powell, and
R L Capizzi, and
E S Lyerly, and
M R Cooper
June 1987,
Seminars in oncology,
B L Powell, and
R L Capizzi, and
E S Lyerly, and
M R Cooper
January 1984,
American journal of hematology,
B L Powell, and
R L Capizzi, and
E S Lyerly, and
M R Cooper
February 1991,
International journal of hematology,
B L Powell, and
R L Capizzi, and
E S Lyerly, and
M R Cooper
June 1985,
Blood,
B L Powell, and
R L Capizzi, and
E S Lyerly, and
M R Cooper
June 1987,
Seminars in oncology,
B L Powell, and
R L Capizzi, and
E S Lyerly, and
M R Cooper
November 1977,
Cancer treatment reports,
B L Powell, and
R L Capizzi, and
E S Lyerly, and
M R Cooper
June 1990,
Cancer,
B L Powell, and
R L Capizzi, and
E S Lyerly, and
M R Cooper
January 1982,
Medical and pediatric oncology,
B L Powell, and
R L Capizzi, and
E S Lyerly, and
M R Cooper
July 1981,
Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
B L Powell, and
R L Capizzi, and
E S Lyerly, and
M R Cooper
January 1973,
Cancer chemotherapy reports,
